- HIV, Drug Use, Sexual Risk
- Opioid Use Disorder Treatment
- COVID-19 and Mental Health
- Hepatitis C virus research
- Homelessness and Social Issues
- HIV/AIDS Research and Interventions
- Psychological Well-being and Life Satisfaction
- Social and Intergroup Psychology
- Substance Abuse Treatment and Outcomes
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Digital Mental Health Interventions
- Cannabis and Cannabinoid Research
- Pregnancy and Medication Impact
- Cultural Differences and Values
- Indigenous Health, Education, and Rights
- Drug-Induced Hepatotoxicity and Protection
- Forensic Toxicology and Drug Analysis
- Resilience and Mental Health
McGill University
2024-2025
Centre Hospitalier de l’Université de Montréal
2021-2025
Fordham University
2023
People who inject drugs (PWID) are a priority population in HCV elimination programming. Overcoming sex and gender disparities risk, prevention, the cascade of care is likely to be important achieving this goal, but these have not yet been comprehensively reviewed.
Abstract Background The COVID-19 pandemic had a disproportionate impact on the health and wellbeing of people who use drugs (PWUD) in Canada. However less is known about jurisdictional commonalities differences exposure impacts pandemic-related restrictions competing social risks among PWUD living large urban centres. Methods Between May 2020 March 2021, leveraging infrastructure from ongoing cohorts PWUD, we surveyed 1,025 participants Vancouver ( n = 640), Toronto 158), Montreal 227),...
People who use drugs (PWUD) are at high risk of experiencing indirect harms measures implemented to curb the spread COVID-19, given reliance on services and social networks. This study aimed document short-term changes in behaviours health-related indicators among PWUD Montreal, Canada following declaration a provincial health emergency Quebec.We administered structured rapid assessment questionnaire members an existing cohort individuals reporting past-year illicit drug recruited via...